文献速递免疫规划

评估全流感病毒颗粒疫苗在食蟹猴中的致热性

Assessing the pyrogenicity of whole influenza virus particle vaccine in cynomolgus macaques.
PubMed 文献 · Vaccine · 2022-12-14

本研究在食蟹猴中评估四价灭活流感全病毒颗粒疫苗(WPV)与裂解病毒疫苗(SV)皮下接种后的发热反应。首次接种WPV后体温升高1°C-2°C并持续6-12小时,第二次接种未见体温升高,SV两次均不影响体温。吲哚美辛预处理可减弱WPV所致发热,WPV还诱导血浆I型干扰素和单核细胞趋化蛋白1升高;半量WPV即可获得足够抗体反应且不引起发热,作者建议评估减量抗原WPV用于临床。

要点

  • 首次接种WPV后体温升高1°C-2°C持续6-12小时,第二次接种未见体温升高。
  • SV在两次接种后均不影响体温。
  • 吲哚美辛预处理可减弱WPV所致发热,提示前列腺素参与。

核心结论

  • 首次接种WPV后体温升高1°C-2°C并持续6-12小时,第二次接种未见体温升高,SV两次均不影响体温。
  • WPV所致发热可能归因于初次免疫应答,且依赖环氧合酶合成前列腺素的增加。
  • 半量WPV即可获得足够抗体反应且不引起发热,作者建议评估减量抗原WPV用于临床,尤其在未免疫人群。

研究设计与样本

  • 研究在食蟹猴中皮下注射四价灭活流感疫苗(药品级或研究用产品),比较WPV与SV接种后的发热反应。

主要发现

  • 首次接种WPV后体温升高1°C-2°C持续6-12小时,第二次接种未见体温升高;SV两次均不影响体温。
  • 吲哚美辛预处理可减弱WPV所致发热。
  • WPV而非SV诱导血浆I型干扰素和单核细胞趋化蛋白1升高。
  • 半量WPV即可获得足够抗体反应且不引起发热。

关键数值与推荐

  • 首次接种WPV后体温升高1°C-2°C持续6-12小时。
  • 半量WPV即可获得足够抗体反应且不引起发热。

临床怎么用

  • 作者建议评估减量抗原WPV用于临床,尤其在未免疫人群。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Among inactivated influenza vaccines, the whole virus particle vaccine (WPV) elicits superior priming responses to split virus vaccine (SV) in efficiently inducing humoral and cellular immunity. However, there is concern for undesired adverse events such as fever for WPV due to its potent immunogenicity. Therefore, this study investigated the febrile response induced by subcutaneous injection with quadrivalent inactivated influenza vaccines of good manufacturing grade for pharmaceutical or investigational products in cynomolgus macaques. Body temperature was increased by 1 °C-2 °C for 6-12 h after WPV administration at the first vaccination but not at the second shot, whereas SV did not affect body temperature at both points. Given the potent priming ability of WPV, WPV-induced fever may be attributed to immune responses that uniquely occur during priming. Since WPV-induced fever was blunted by pretreatment with indomethacin (a cyclooxygenase inhibitor), the febrile response by WPV is considered to depend on the increase in prostaglandins synthesized by cyclooxygenase. In addition, WPV, but not SV, induced the elevation of type I interferons and monocyte chemotactic protein 1 in the plasma; these factors may be responsible for pyrogenicity caused by WPV, as they can increase prostaglandins in the brain. Notably, sufficient antibody responses were acquired by half the amount of WPV without causing fever, suggesting that excessive immune responses to trigger the febrile response is not required for acquired immunity induction. Thus, we propose that WPV with a reduced antigen dose should be evaluated for potential clinical usage, especially in naïve populations.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ohno M, Sagata M, Sekiya T, et al. Assessing the pyrogenicity of whole influenza virus particle vaccine in cynomolgus macaques. Vaccine. 2022. PMID: 36526501. doi:10.1016/j.vaccine.2022.12.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。